Zhou H - Search Results

1

TRPM8 overexpression suppresses hepatocellular carcinoma progression and improves survival by modulating the RTP3/STAT3 pathway.

Chen L, Xu N, Gou D, Song J, Zhou M, Zhang Y, Zhang H, Zhu L, Huang W, Zhu Y, Gao C, Gu D, Xu Y, Zhou H. Chen L, et al. Among authors: zhou h, zhou m. Cancer Med. 2024 Oct;13(19):e70109. doi: 10.1002/cam4.70109. Cancer Med. 2024. PMID: 39385506 Free PMC article.

2

Hepatocellular Carcinoma Differentiation: Research Progress in Mechanism and Treatment.

Song J, Zhou H, Gu D, Xu Y. Song J, et al. Among authors: zhou h. Front Oncol. 2022 Jan 12;11:790358. doi: 10.3389/fonc.2021.790358. eCollection 2021. Front Oncol. 2022. PMID: 35096588 Free PMC article. Review.

3

DDX56 transcriptionally activates MIST1 to facilitate tumorigenesis of HCC through PTEN-AKT signaling.

Zhou H, Du Y, Wei X, Song C, Song J, Xu N, Huang W, Chen L, Yao F, Du D, Qiu C, Zhong L, Liu Y, Gu D, Wang J, Xu Y. Zhou H, et al. Theranostics. 2022 Aug 15;12(14):6069-6087. doi: 10.7150/thno.72471. eCollection 2022. Theranostics. 2022. PMID: 36168636 Free PMC article.

4

Human liver cancer organoids: Biological applications, current challenges, and prospects in hepatoma therapy.

Chen L, Wei X, Gu D, Xu Y, Zhou H. Chen L, et al. Among authors: zhou h. Cancer Lett. 2023 Feb 28;555:216048. doi: 10.1016/j.canlet.2022.216048. Epub 2023 Jan 2. Cancer Lett. 2023. PMID: 36603689 Review.

5

DDX17-regulated alternative splicing that produced an oncogenic isoform of PXN-AS1 to promote HCC metastasis.

Zhou HZ, Li F, Cheng ST, Xu Y, Deng HJ, Gu DY, Wang J, Chen WX, Zhou YJ, Yang ML, Ren JH, Zheng L, Huang AL, Chen J. Zhou HZ, et al. Hepatology. 2022 Apr;75(4):847-865. doi: 10.1002/hep.32195. Epub 2021 Dec 21. Hepatology. 2022. PMID: 34626132 Free PMC article.

6

Intracellular hydrogelation of macrophage conjugated probiotics for hitchhiking delivery and combined treatment of colitis.

Wang J, Hu D, Chen Q, Liu T, Zhou X, Xu Y, Zhou H, Gu D, Gao C. Wang J, et al. Among authors: zhou x, zhou h. Mater Today Bio. 2023 May 19;20:100679. doi: 10.1016/j.mtbio.2023.100679. eCollection 2023 Jun. Mater Today Bio. 2023. PMID: 37273799 Free PMC article.

7

CRISPR-HOLMES-based NAD⁺ detection.

Zhuang S, Hu T, Zhou H, He S, Li J, Zhang Y, Gu D, Xu Y, Chen Y, Wang J. Zhuang S, et al. Among authors: zhou h. Front Bioeng Biotechnol. 2024 Mar 25;12:1355640. doi: 10.3389/fbioe.2024.1355640. eCollection 2024. Front Bioeng Biotechnol. 2024. PMID: 38590607 Free PMC article.

8

meHOLMES: A CRISPR-cas12a-based method for rapid detection of DNA methylation in a sequence-independent manner.

Zhuang S, Hu T, Zhou X, Zhou H, He S, Li J, Qiu L, Zhang Y, Xu Y, Pei H, Gu D, Wang J. Zhuang S, et al. Among authors: zhou x, zhou h. Heliyon. 2024 Jan 17;10(2):e24574. doi: 10.1016/j.heliyon.2024.e24574. eCollection 2024 Jan 30. Heliyon. 2024. PMID: 38312601 Free PMC article.

9

PBK overexpression promotes metastasis of hepatocellular carcinoma via activating ETV4-uPAR signaling pathway.

Yang QX, Zhong S, He L, Jia XJ, Tang H, Cheng ST, Ren JH, Yu HB, Zhou L, Zhou HZ, Ren F, Hu ZW, Gong R, Huang AL, Chen J. Yang QX, et al. Among authors: zhou l, zhou hz. Cancer Lett. 2019 Jun 28;452:90-102. doi: 10.1016/j.canlet.2019.03.028. Epub 2019 Mar 23. Cancer Lett. 2019. PMID: 30914208

10

Overexpression of ubiquitin-conjugating enzyme E2 L3 in hepatocellular carcinoma potentiates apoptosis evasion by inhibiting the GSK3β/p65 pathway.

Tao NN, Zhang ZZ, Ren JH, Zhang J, Zhou YJ, Wai Wong VK, Kwan Law BY, Cheng ST, Zhou HZ, Chen WX, Xu HM, Chen J. Tao NN, et al. Cancer Lett. 2020 Jul 1;481:1-14. doi: 10.1016/j.canlet.2020.03.028. Epub 2020 Apr 5. Cancer Lett. 2020. PMID: 32268166

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35,720 results

Search Page

Filters